Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$238,303,971
+$60,761,688 QoQ
Shares Held
198,681
+2.9% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#239
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $998,315,428 across 11 Drug Manufacturers - General names. LLY ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,949,177 | $369,602,942 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
198,681 | $238,303,971 | |
| 3 | ABBV |
AbbVie Inc.
|
435,569 | $109,606,583 | |
| 4 | AMGN |
Amgen Inc
|
299,765 | $108,550,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
454,397 | $58,390,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
363,947 | $45,981,063 | |
| 7 | JNJ |
Johnson & Johnson
|
178,793 | $45,408,058 | |
| 8 | PFE |
Pfizer Inc
|
376,556 | $9,067,468 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,303,971 | 198,681 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $177,542,283 | 193,029 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $214,439,517 | 199,538 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $152,619,838 | 200,026 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $142,220,571 | 182,444 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $121,066,017 | 146,585 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $113,504,844 | 147,027 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $109,344,486 | 123,422 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $112,795,861 | 124,584 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $100,285,267 | 128,908 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $81,092,332 | 139,114 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $59,829,299 | 111,387 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $49,938,866 | 106,484 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $29,799,240 | 86,772 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $34,241,160 | 93,596 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $31,257,921 | 96,669 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,774,266 | 122,673 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $24,306,226 | 84,877 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $23,278,716 | 84,276 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,364,793 | 75,156 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,555,352 | 89,558 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,390,513 | 93,087 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,271,522 | 31,222 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,743,199 | 45,556 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,338,373 | 50,788 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $50,844,764 | 366,528 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||